ARTICLE | Data Byte
Translational spotlight on East-West innovation
Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities
November 23, 2022 1:29 AM UTC
Preclinical innovations from cross-border teams captured in BioCentury’s Distillery include a PUS7-inhibiting compound for glioblastoma, a NOD2-activating bacterial enzyme for colitis, and a natural product-based, non-hormonal male contraceptive.
BioCentury’s Distillery, a curated collection of translational studies from more than 25 journals, provides brief summaries of preclinical papers that showcase targets and technologies with disease-modifying effects...
BCIQ Company Profiles
Beckman Research Institute of City of Hope
Chinese University of Hong Kong
National Center for Nanoscience and Technology
National Health Commission of the People's Republic of China